CD59 and rheumatoid arthritis: More precisely, intraarticular injection of membrane-targeted CD59 or Fc fusion proteins containing CD59 in place of the Fab arms of the antibody markedly ameliorated the severity of antigen-induced arthritis (AIA) in mice, indicating the therapeutic efficacy of CD59 in RA (Harris et al., 2002; Williams et al., 2004).